← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 9, 2018Last known activity
Jun 24, 2022
Timeline
2010s
- Jun 1, 2015
Magenta Therapeutics— Founded
Drugs by trial phase (4 distinct, 6 trials)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT05445128Lead sponsorPhase 2Jun 24, 2022
- NCT05445128Study directorPhase 2Jun 24, 2022
- NCT05223699Lead sponsorPhase 1Feb 14, 2022
- NCT04762875Lead sponsorPhase 2Jun 16, 2021
- NCT04154670Study directorPhase 1Nov 7, 2019
- NCT04154670Lead sponsorPhase 1Nov 7, 2019
- NCT03932864Lead sponsorPhase 1Apr 22, 2019
- NCT03406962Study directorPhase 2Feb 9, 2018
- NCT03406962Lead sponsorPhase 2Feb 9, 2018
Details
- Founded
- Cambridge, MA, US Jun 1, 2015
- Last known activity
- Jun 24, 2022